May 12 is ME/CFS Awareness Day. Fuel progress all month long—join the May Momentum campaign!

Nanoneedle Diagnostic Tool

The technology will be optimized for easy clinical adoption and scaled up so that numerous FDA-approved drugs can be simultaneously screened as potential treatments.

Metabolic Trap Study

The aim of this study was to test the hypothesis developed by Dr. Phair that a crucial component of metabolism in ME/CFS patients appears to be “trapped” in an unhealthy state.

Severely iIl Patient

The goal of the Severely ill Patient Study was to conduct a comprehensive “Big Data” analysis on severely ill ME/CFS patients in order to begin an exploration to find the molecular basis of ME/CFS.

T cells and Immunology

The study’s objective was to establish the role of T cells and the immune system in ME/CFS by examining the genetic material in T cells — immune cells that identify and kill infected cells.